Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Contractors are hired to work for a company, while they aren't technically employees of the that company. I know b/c I used to be a contractor for a tech company awhile back. I technically worked for company A, but company B hired company A who then hired me to perform specific type work for a period of time. Company A is the middle man. I was full-time, but I was not considered "permanent" until company B hired me. You had stated,
According to Biel's official press releases at the time, he did work for them as their 3rd party IR rep.
http://www.prnewswire.com/news-releases/bioelectronics-corporation-receives-major-orders-from-italian-distributor-57115537.html
http://www.prnewswire.com/news-releases/bioelectronics-announces-major-clinical-trials-57305837.html
http://www.prnewswire.com/news-releases/bioelectronics-announces-conference-call-to-update-investors-on-growth-initiatives-57254512.html
A number of investors contacted the company at the time and Joe was the one who responded with the answers from the company.
What's up with these 88,888 trades? 5 times in the last 4 days that they've popped up to bring the PPS back up to .0002.
Nope, only 68M.
One thing I noticed was the activity around the end/beginning of the last couple of quarters. Let's see if history repeats itself.
I wonder if the volume will end up around 80+M.
Damn Stockcharts.
Their competitors do it daily on Instagram to increase brand awareness. IG & FB make for better visual marketing.
Not sure about that.
Just "odd" that they put out a PR for the share structure decrease, then turn around and increase things again.
No, A/S for Kat Exploration was raised back up to 2.03B.
http://nvsos.gov/sosentitysearch/
Thanks for the correction.
Accum/Distr was flat, but the CMF is starting an uptrend. Looking at the charts, I figured we'd see .0001 again, and we did early this morning. I was surprised by the volume today. I wouldn't get too excited until this thing breaks .0003 though. Might be seeing a good flip here if you got in early enough.
http://stockcharts.com/h-sc/ui?s=KATX&p=D&b=5&g=0&id=p96658240761
Stockcharts says that is the reason.
Updating the rapidly diluting share structure from calculations based on the SEC filings from Tangiers that contradicts a 4.5 month old PR has no relevance to facts with KATX? OK.
Again, it's an informative post to update the share structure. It may not be informative to you. That's fine. Notice that my post was not a response to any of your 4 other posts at the time. Many times new traders/investors look through this board for information, it may be helpful to them.
And this increase in O/S, after increasing the A/S to over 2B relatively quickly after this PR:
http://finance.yahoo.com/news/kat-exploration-reduces-authorized-shares-123000832.html
only adds to what several have been saying about the Steads for years now about their trustworthiness with respect to retail investors.
It is an informative post. The higher the O/S goes, the less likely it goes to 50 cents like some had predicted.
Do you not have anything to add to any part of the KATX discussion or are you just going to piggyback posts with pointless questions? If you had something to add that wasn't unsubstantiated hearsay, maybe we all can talk about that instead.
O/S increased by 20% in 10 days, and overall has increased in the neighborhood of 129% since the last financials.
Little bit ago, there was talk about positive PPS movement due to the low float, supply and demand, etc. Despite the optimism, several of us warned that dilution was coming. Doesn't look like things are currently working in a direction that's going to highlight the optimism in that past discussion.
New filing:
Tangiers Investment Group, LLC owns 34.4M shares of common stock which equates to 5.82% as of Aug 31. This should calculate out to 591.07M shares of common stock outstanding.
On Aug 21, they owned 48.89M shares which equated to 9.92% of common stock. As stated in the prev post, this should calculate out to 492.8M shares of common stock outstanding.
Unless someone posted a news article with a picture, or the court filings, I would doubt the legitimacy.
By today's filing, the O/S should be around 492.8M. That's almost an increase of 300M shares since May 12.
No different than many of the OTC stocks I've seen. The biggest supporters become the harshest critics for varying reasons.
Few (if any) are happy with the PPS drop over the last couple of months. There are always those who like to grab "cheapies". Voicing frustrations on this board or elsewhere is expected.
I jumped in this stock a little bit ago anticipating good news in the 2nd half of the year. Even if the O/S is fully diluted according to the various agreements, IMO the float is still low enough for this to move significantly with good news. There is always risk though. Everyone should have their own plan worked out.
I'm not sure what ILNS would be able to say right now. Seems like the TauC3 is still being studied. The data for Phase 1B of OX1/SHP622 is still being evaluated. Maza might know the preliminary results of Shire's clinical tests, but he's not putting that info out before Shire is ready.
Unless there is a significant milestone payment later this year, IMO they will have to raise more money for 2016.
Unless shareholders have the majority of the vote, they aren't going to be able to replace Maza. Most OTC CEOs should know that. That is why they keep a poison pill in their back pocket and probably why the ILNS A/S is still at 2B.
For me, it's a waiting game.
I had hoped that Shire's last 10-Q provided some info on OX1/SHP622. Not much other than positive sentiment about the results from 2010.
ILNS's fiscal year ended in June. Their financials are due by the end of September (90 days).
And he has to file with the SEC for holding 200M shares.
IMO, not w/o a R/S (which could happen).
They dropped the hemp stuff which could have acted as a nice catalyst if they had some type of substantial news. May see some upward movement again b/c they are doing something behind the scenes since they are creating a new website along with all of the filings we've seen this year.
Long term: I don't like their attempt at mining exploration.
I am still passively watching this stock, but I have recently looked at different aspects of this company, including a glance at the recent financials.
Nulief
I found it to be interesting that neither company mentioned Nulief in their financials. As a method of transparency in the partnership, they both need to eventually provide an official update for their shareholders.
My On-going Concern and some thoughts in print
What has the market been like for other CBD supplement manufacturers? I'm asking b/c I haven't been able to dig up info on that subject yet. I'm wondering if anyone else has. It would be a good reference to what NRTI would have been able to do if they had been selling Nulief in Oakland.
I'm probably in the minority here, but Nulief being sold in a single dispensary in Oakland wasn't high on my concern list for this company. That is part of the reason why I didn't buy any additional stock in the last 1.5 years after all of the hype from the company and individual investors. I'm not sure that even if they had been selling Nulief, that the revenue would have been sufficient enough to replace the lost revenue of the Martha Stewart line which was apparently -$274.8K in 2Q15 vs 2Q14.
As I see it, no matter how people want to sugarcoat it with the health benefits, the main market (and hence high revenue) is for marijuana smokers looking for a high. NRTI's partner has seen about $430+k in 6 months from cannabis sales. Don't get me wrong. There is a need for CBD, and I believe that market in the US will gain better traction and grow exponentially once official clinical data (ie. FDA approved) is gathered. As I've stated before, in more ways than one that clinical data situation opens up things. As I've stated before, the clinical data route with FDA approval would have been a smarter long-term approach to the CBD market for TRTC and NRTI. That would cost the two companies some money in the short term to conduct the trials.
The company has stated it is in need of additional financing and is actively seeking it. Awhile back, I think it was CN who spoke to James and said that if anyone had alternative forms of financing that was less toxic, then James would gladly listen. I'm asking out of true curiosity, did anyone take him up on that offer? Dealing with all of the Federal issues hovering over the mj and CBD industry, I'm not sure what the financing situation in the overall industry is like. I heard from one other company and read in several reports that it has been very difficult. From April 2016 to July 2016 there is quite a bit of debt due since they renegotiated some of the terms of their debt and receive additional financing. That means if the revenue situation doesn't improve dramatically, then investors can expect heavy dilution next year.
As I've stated before, I expect a reverse split sooner rather than later so the company can stay on OTCQB.
My concern with the company is the same as it has been for the past 4-5 years, traction in the sales of Surgex as well as Bikini Ready. Those are billion-dollar industries. The customer reviews I have seen for the two lines are promising. Between 2011 and 2014, a 3-yr contract with West Point was created for Surgex. There is clinical data proving Surgex's effectiveness. Significant sales of other lines is a bonus for me. Over the past few weeks, I noticed a glaring and significant marketing weakness from Inergetics. After a short (and somewhat testy) email exchange, that issue is supposed to be addressed. We shall see if they took my advice seriously.
Closing thoughts
Years ago, someone once posted that penny stocks are penny stocks for a reason. That is a hard lesson I learned many years ago, and is something I continue to see from the dozens of stocks in various sectors I have watched over the years. That is a lesson that some may be learning now. Some are scams. From what I have seen, if a penny stock doesn't have millions in revenue per quarter, and millions in cash, there is a high probability of raising cash, which means increasing debt, and hence the inevitable dilution. In some cases, having significant revenue and cash hasn't meant safety from dilution due to the company's burn rate for the different projects they are working on. That is why it is much tougher to invest (hold for months to years) in penny stocks as opposed to trading them.
If she was around, she probably isn't anymore.
Kuni won't need her for mining.
Never seen it like that, esp when I didn't see any T-trades.
Why does IHUB and Yahoo Finance show .0001, while I'm seeing .0002 on Google Finance, OTCMarkets, and Etrade?
Very true.
I get that he was responding to comments/criticisms. Just looking at the possible meaning since it was vague. Just saying it may have been cryptic with all that is unfolding.
All this may also explain the tweet by Kras that said, "Nulief launched. Market conditions change..."
Hopefully more information is disclosed as things unfold in this case. If an FBI investigation is involved, it makes sense that officers for both companies may not be commenting on things at this time.
While I won't dismiss some claims against NRTI b/c this is the OTC world after all and stranger things have (probably) happened, IMO things don't add up in those claims. Why would NRTI now put up a fraudulent launch after working to launch all their other product lines? Why would TRTC, who is trying to launch hemp/mj product lines across the country, employ and work with someone doing such a thing, esp when the FBI has been digging into things for the past couple of years? Then, give him a $500k bonus. That would be playing with fire while wearing gasoline as cologne. Where I will agree that there is a conflict of interest for Mr. James. I don't mind insider connections, but he's straddling 2 horses.
If my math is correct, today's filing indicates the O/S is around 343M - for anyone keeping score.
MM's are the likely answer. IMO, no retail investor is placing a trade at a fraction of penny (I know some like to believe in investor manipulation). That's why this stock has me curious.
I'm waiting for a trade at .0001 soon.
Bikini Ready actually has pretty good reviews on Amazon.
http://www.amazon.com/s/ref=nb_sb_ss_c_0_12?url=search-alias%3Dhpc&field-keywords=bikini+ready&sprefix=bikini+ready%2Caps%2C205
TBH, it should have a marketing campaign similar to what Shredz is doing. I see a lot of fit amateurs posting on social media about it. That is the direction I was trying to get this management to take years ago with Surgex and Chelsie.
Surgex has good reviews, but there are so few that I don't know if they belong to actual (unbiased) customers or investors. :) Problem is that Surgex has little to no marketing. I was at the Mr. Olympia Expo last year, and couldn't find a Surgex booth. Unless it was hidden in a corner somewhere, I don't think there was representation. I will admit to being distracted by the fitness models scattered all throughout the floor.
http://www.amazon.com/s/ref=nb_sb_noss_1?url=search-alias%3Dhpc&field-keywords=surgex
Slimtrim has poor reviews. Should either reformulate or drop the line.
http://www.amazon.com/Slim-Trim-Weight-Product-Count/dp/B00CE92EJA
FWIW, they also updated their OTC Profile.
~Date for A/S, O/S, Float
~Website updated (although still not active)
~Shareholders of record now 127 instead of 137
http://www.otcmarkets.com/stock/PIHN/profile
This is only some FYI as I'm not recommending any type of trade of this stock for anyone who reads this.
Hard disassociate the two companies when that completely different company has your CEO/CFO as its CFO.
Last year, on several occasions I watched NRTI's stock being driven by good news from the other company, even when NRTI wasn't named in the PR. I wondered what was happening since I didn't see any PR notifications from NRTI. That buying was speculation-based. Whether we like it or not, the two are linked, good and bad.
Like I said, time will tell. I'm watching things unfold. Just thought it was good FYI for investors of NRTI to see interesting info unfold on NRTI's mj/hemp partner under relevant circumstances.
Pretty much.
NRTI does not exist in a vacuum. Good to be aware of things happening elsewhere that may affect them.
Directly, no. Indirectly, possibly since there are links between the two companies and their marijuana/hemp business interests as stated in previous PRs as well as the situation w/ Mr. James.
I'm trying to limit the details as to not drone on about the situation with numerous posts. It is an interesting turn of events.
As I pointed out earlier, I don't see TRTC wishing to be associated with any other fraudulent activity as it will look worse for them than it already does having been associated with the current FBI scandal. So if the partnership between TRTC and NRTI doesn't dissolve, that may say something contrary to what some on this board may believe. If it does dissolve, then that may reaffirm what some have tried to point out with NRTI. Time will tell.
It was Martin Kaufman who cooperating with the FBI. He supplied a $600k loan to the guy who is the subject of the FBI investigation. Kaufman is associated with MediFarm, a subsidiary of TRTC. Peterson's involvement was in conversations on unfair labor practices and the blocking of unionization efforts in Nevada dispensaries. Kaufman and Peterson were threatened if they ever tried to recoup the loan b/c "the loans were part of a deal involving "unclean hands to launder (medical marijuana) money.” Feds aren't going after Peterson or Kaufman, so that was (perhaps) the motivation to get Kaufman to work with them.
In any case, it looks bad for TRTC to be involved with this guy, so I imagine that they are not looking to work with any more shady partners. If the claims by some against NRTI have merit, in time things will work themselves out between TRTC and NRTI.